CIK 0001661059
- Non-accelerated filer
- Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475231247
- Phone
- +1 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- Open-market buys, last 90 days
- $140,487
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$140,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-13 | Sofinnova Venture Partners IX, L.P. 10% owner | Purchase | +400,000 | $15.00 | $6.0M | 2,521,856 |
| 2019-05-13 | SHANNON TIMOTHY M Director | Purchase | +50,000 | $15.00 | $750K | 2,254,442 |
| 2019-05-13 | Khuong Chau Quang Director | Purchase | +350,000 | $15.00 | $5.3M | 2,711,013 |
| 2019-05-13 | Xu Stella Director | Purchase | +125,000 | $15.00 | $1.9M | 1,103,570 |
| 2019-05-13 | CANAAN X L.P. 10% owner | Purchase | +50,000 | $15.00 | $750K | 2,254,442 |
| 2019-05-13 | ORBIMED ADVISORS LLC Director | Purchase | +350,000 | $15.00 | $5.3M | 2,711,013 |
Page 2 of 2 · 26 trades